BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16781233)

  • 1. Bare metal stent restenosis is not a benign clinical entity.
    Chen MS; John JM; Chew DP; Lee DS; Ellis SG; Bhatt DL
    Am Heart J; 2006 Jun; 151(6):1260-4. PubMed ID: 16781233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era.
    Lee MS; Pessegueiro A; Zimmer R; Jurewitz D; Tobis J
    J Invasive Cardiol; 2008 Aug; 20(8):401-3. PubMed ID: 18688064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical in-stent restenosis with bare metal stents: is it truly a benign phenomenon?
    Bainey KR; Norris CM; Graham MM; Ghali WA; Knudtson ML; Welsh RC;
    Int J Cardiol; 2008 Aug; 128(3):378-82. PubMed ID: 17689711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis.
    Drozd J; Wójcik J; Małek R; Korona B; Zapolski T; Wysokiński A
    Kardiol Pol; 2010 Jun; 68(6):637-45. PubMed ID: 20806192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical presentation of restenosis after bare metal stent implantation: behind a facade of benignity.
    Celik T; Iyisoy A; Yuksel C; Jata B; Isik E
    Int J Cardiol; 2009 Jul; 135(3):401-3. PubMed ID: 18571254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
    J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial).
    Assali AR; Moustapha A; Sdringola S; Denktas AE; Willerson JT; Holmes DR; Smalling RW
    Am J Cardiol; 2006 Sep; 98(6):729-33. PubMed ID: 16950172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis.
    Singh IM; Filby SJ; Sakr FE; Gorodeski EZ; Lincoff AM; Ellis SG; Shishehbor MH
    Catheter Cardiovasc Interv; 2010 Feb; 75(3):338-42. PubMed ID: 19937786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
    Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
    Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of in-stent restenosis on death and myocardial infarction.
    Steinberg DH; Pinto Slottow TL; Buch AN; Javaid A; Roy PK; Garg S; Okabe T; Torguson R; Smith KA; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2007 Oct; 100(7):1109-13. PubMed ID: 17884372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation.
    Stone GW; Ellis SG; Colombo A; Dawkins KD; Grube E; Cutlip DE; Friedman M; Baim DS; Koglin J
    Circulation; 2007 Jun; 115(22):2842-7. PubMed ID: 17515458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Everolimus- and zotarolimus-eluting stents for bare metal stent in-stent restenosis treatment: a prospective study.
    Toutouzas K; Patsa C; Tsiamis E; Tsioufis C; Spanos A; Stefanadi E; Tentolouris C; Stefanadis C
    J Interv Cardiol; 2008 Oct; 21(5):388-94. PubMed ID: 18705639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of infarction-related artery occlusion and multivessel disease in postinfarction angina.
    Valenzuela LF; Vázquez R; Fournier JA; Cubero J; Maraví J; Cruz-Fernández JM; Kaski JC
    Int J Cardiol; 2007 Feb; 115(3):381-5. PubMed ID: 16814417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal in-stent restenosis and in-stent thrombosis within the same bare-metal stent 5 years after deployment in a saphenous vein graft.
    Ponnuthurai FA; van Gaal WJ; Channon KM
    J Invasive Cardiol; 2007 Dec; 19(12):E369-71. PubMed ID: 18180530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.